UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2009, Document of the World Bank, ISBN 0821377582, xiii, 133
prevention & control | Malaria | International Agencies | World Bank | Booster Program for Malaria Control in Africa | Africa | LEADING CAUSE OF DEATH | TETANUS | SPECIES | CONTRACTING MALARIA | GAMBIAE COMPLEX | TREATMENT | SERVICE DELIVERY | FALCIPARUM RESISTANCE | HEALTH SECTOR | MORBIDITY | HUMAN DEVELOPMENT | BURDEN OF DISEASE | ECONOMIC GROWTH | HEALTH SYSTEMS | ORAL REHYDRATION THERAPY | POTENTIAL CONTRIBUTION | PREGNANCY | PUBLIC HEALTH EXPENDITURE | HEALTH WORKERS | MALARIA ILLNESS | RESPIRATORY DISTRESS | TROPICAL DISEASES | MALARIA RATES | HEALTH SERVICES | MALARIA | ANEMIA | NATIONAL LEVEL | INSECTICIDE-TREATED NETS | MALARIA-ENDEMIC AREAS | DISASTERS | MORTALITY | PATIENTS | TUBERCULOSIS | IMPACT ON HEALTH | RISK OF MALARIA | IMPACT OF MALARIA | MALARIA INTERVENTIONS | CLIMATE CHANGE | NETS | MALARIA REPORT | DECISION MAKING | MALARIA PREVENTION | MALARIA PARASITE | NATIONAL MALARIA CONTROL | MALARIA MORBIDITY | ANOPHELES | INFORMATION SYSTEM | CONTROL OF MALARIA | HEAVY MALARIA BURDEN | HEALTH PLANNING | ANTIMALARIAL DRUGS | MEASLES IMMUNIZATION | TRANSMISSION CONTROL | ACCESS TO EFFECTIVE TREATMENT | POPULATION STRATEGY | PRIMARY EDUCATION | CEREBRAL MALARIA | HEALTH OUTCOMES | MALARIA DEATHS | PROPHYLACTIC USE | MALARIA CASES | MEDICINES | MALARIA CONTROL ACTIVITIES | AGRICULTURAL PRODUCTION | FAMILIES | DISABILITY | COMPLICATIONS | HEALTH INTERVENTIONS | MEDICAL RESEARCH | INFANT | MINISTERS OF HEALTH | MALARIA INFECTIONS | DISEASE OF POVERTY | FEBRILE ILLNESS | HEALTH SYSTEM | TREATMENT SERVICES | MOSQUITO VECTORS | HUMAN IMMUNODEFICIENCY VIRUS | HOSPITAL | HYPOGLYCEMIA | LOW BIRTHWEIGHT | QUALITY ASSURANCE | MALARIA CONTROL EFFORTS | WAR | RURAL AREAS | MEDICINE | IMMUNIZATION | MALARIA MORTALITY | MALARIA CONTROL | NATIONAL HEALTH SYSTEMS | MALARIA BURDEN | PROGRESS | BED NETS | ECONOMIC DEVELOPMENT | WORLD HEALTH ORGANIZATION | PARASITIC DISEASE | MALARIA PROGRAM | SUSTAINABLE DEVELOPMENT | IRON | HEALTH CARE | SCARCE RESOURCES | MORTALITY REDUCTION | PUBLIC HEALTH PROBLEM | MALARIA RISK | DRUG RESISTANCE | EFFECTIVE USE | NEEDS FOR INFORMATION | ECONOMIC PRODUCTIVITY | MILLENNIUM DEVELOPMENT GOAL | ANOPHELES MOSQUITO | PREVENTABLE DISEASE | REHABILITATION | INFECTION | BRAIN | CHILD SURVIVAL | INTERNATIONAL COMMUNITY | WORKERS | MALARIA DATABASE | MATERNAL MORTALITY RATIO | ORAL REHYDRATION | SEVERE ANEMIA | RESOURCE NEEDS | DISSEMINATION | PERINATAL MORTALITY | NUTRITION | RISK OF DEATH | PUBLIC HEALTH | NUMBER OF HOUSEHOLDS | MEASLES | MANDATES | TREATMENT OF MALARIA | DEVELOPMENT POLICIES | LONGEVITY | MALARIA IN PREGNANCY | ISOLATION | ANOPHELES FUNESTUS | HIGH MALARIA TRANSMISSION | GLOBAL EFFORT | BURDEN OF MALARIA | INFANT DEATHS | INTERVENTION | STILLBIRTH | HIV/AIDS | MALARIA CONTROL PROGRAMS | VULNERABLE POPULATIONS | MALARIA VECTORS | MALARIA-ENDEMIC COUNTRIES | NEGATIVE EFFECTS | DEATH RATES | MATERNAL MORTALITY | DISEASES | HIV | SULFADOXINE | PUBLIC HEALTH BURDEN | LEGAL STATUS | MILLENNIUM DEVELOPMENT GOALS | PATIENT | SOCIAL REHABILITATION | NATURAL DISASTERS | INSECTICIDES | INFECTIONS | HEALTH PROBLEMS | CAPACITY BUILDING | MALARIA INFECTION | VECTOR CONTROL PROGRAMS | ANOPHELES MOSQUITOES | MALARIA PARASITES | REPRODUCTIVE HEALTH | ANTIMALARIAL | MALARIA PROGRAMS | PREVENTIVE TREATMENT | MOSQUITO POPULATIONS | VECTORS | PARASITOLOGY | PRETERM DELIVERY | DIAGNOSIS | BRAIN DAMAGE | CLINICAL MALARIA | DISEASE CONTROL | MORBIDITY AND MORTALITY | MISCARRIAGE | POVERTY REDUCTION | VICIOUS CYCLE | GENDER EQUALITY | UNCOMPLICATED MALARIA | CHILD DEATHS | DEWORMING | IMMUNODEFICIENCY | ACQUIRED IMMUNE DEFICIENCY SYNDROME | PLASMODIUM FALCIPARUM | PYRIMETHAMINE | BACK MALARIA | INTERNATIONAL ORGANIZATIONS | CHLOROQUINE RESISTANCE | CHILD MORTALITY | SUSTAINABLE MALARIA CONTROL | TECHNICAL RESOURCES | MINISTRIES OF HEALTH | MALNUTRITION | HEALTH FACILITIES | PREGNANT WOMEN | NUMBER OF CHILDREN | HEALTH CARE SERVICES | THERAPIES | EQUITABLE ACCESS | REGIONAL NEEDS | RESIDUAL SPRAYING | MALARIOUS AREAS | POLICY MAKERS | CYCLE OF POVERTY | ADULT MOSQUITO | HEALTH SURVEYS | VECTOR CONTROL | IMMUNE DEFICIENCY | MALARIA TREATMENT
Book
2006, ISBN 0300108990, viii, 296
Book
The Lancet infectious diseases, ISSN 1473-3099, 2015, Volume 15, Issue 12, pp. 1450 - 1458
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Malaria, Falciparum - prevention & control | Protozoan Proteins - antagonists & inhibitors | Humans | Vaccination | Infant | Male | Plasmodium falciparum - drug effects | Plasmodium falciparum - immunology | Incidence | Malaria Vaccines - chemistry | Malaria, Falciparum - blood | Antibodies, Protozoan - blood | Immunization, Secondary | Malaria Vaccines - immunology | Female | Protozoan Proteins - chemistry | Plasmodium falciparum - chemistry | Vaccines, Subunit | Tanzania | Treatment Outcome | Ghana | Kenya | Malaria, Falciparum - parasitology | Malaria Vaccines - administration & dosage | Malaria, Falciparum - immunology | Protozoan Proteins - immunology | Malaria | Parasitic diseases | Analysis | Malaria vaccine | Clinical trials | Product development | Vaccines | Health aspects | Studies | Antigens | Hepatitis | Animal vaccines | Immunoglobulins | Population | Infections | Regression analysis | Estimates | Age | Index Medicus | Assaigs clínics | Plasmodium falciparum | Vacuna de la malària | Malària
Journal Article
Journal of vector borne diseases, ISSN 0972-9062, 2003
Journal
Clinical infectious diseases, ISSN 1058-4838, 9/2009, Volume 49, Issue 6, pp. 852 - 860
Malaria | Anemia | Hospital admissions | Respiratory distress | Infections | Parasitism | Parasites | ARTICLES AND COMMENTARIES | Parasitemia | Falciparum malaria | Blood | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Parasitic diseases | Protozoal diseases | Biological and medical sciences | Human protozoal diseases | Medical sciences | Prospective Studies | Blood Chemical Analysis | Parasitemia - diagnosis | Humans | Middle Aged | Male | Parasitemia - drug therapy | Young Adult | Malaria, Vivax - complications | Plasmodium falciparum - isolation & purification | Respiratory Tract Diseases - parasitology | Malaria, Falciparum - diagnosis | Malaysia - epidemiology | Adult | Female | Malaria, Falciparum - drug therapy | Thrombocytopenia - etiology | Malaria, Vivax - parasitology | Parasitemia - complications | Thrombocytopenia - parasitology | Chloroquine - therapeutic use | Malaria - diagnosis | Malaria, Vivax - diagnosis | Antimalarials - therapeutic use | Hospitalization | Malaria, Falciparum - complications | Malaria, Falciparum - parasitology | Plasmodium knowlesi - isolation & purification | Respiratory Tract Diseases - etiology | Animals | Malaria, Vivax - drug therapy | Primaquine - therapeutic use | Adolescent | Malaria - parasitology | Plasmodium vivax - isolation & purification | Parasitemia - parasitology | Malaria - complications | Aged | Malaria - drug therapy | Hemoglobins - analysis | Plasmodium | Care and treatment | Patient outcomes | Causes of | Development and progression | Identification and classification | Medical treatment | Index Medicus
Journal Article
2012, ISBN 0817317600, xv, 283
Book
2010, acls humanities e-book, ISBN 9780521459105, xviii, 371
Book
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 383, Issue 9918, pp. 723 - 735
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Malaria | Parasitic diseases | Protozoal diseases | Biological and medical sciences | Human protozoal diseases | Medical sciences | Malaria, Falciparum | Malaria, Vivax | Pregnancy Complications, Infectious - parasitology | Humans | Asia, Southeastern - epidemiology | Pregnancy Complications, Infectious - physiopathology | Quinine - therapeutic use | Insecticide-Treated Bednets | Mefloquine - therapeutic use | Malaria - epidemiology | Sulfadoxine - therapeutic use | Pregnancy Complications, Infectious - prevention & control | Female | Seasons | Amodiaquine - therapeutic use | Drug Therapy, Combination | Drug Resistance | Insecticides - pharmacology | Pyrimethamine - therapeutic use | Drug Administration Schedule | Pregnancy Complications, Infectious - epidemiology | Chloroquine - therapeutic use | Malaria - diagnosis | Antimalarials - therapeutic use | Malaria - prevention & control | Pregnancy | Anopheles | Animals | Artemisinins - therapeutic use | Malaria Vaccines - administration & dosage | Malaria - pathology | Pregnancy Complications, Infectious - drug therapy | Primary Prevention - methods | Malaria - physiopathology | Malaria - complications | Quinolines - therapeutic use | Malaria - drug therapy | Africa South of the Sahara - epidemiology | Drug Combinations | Prognosis | Research | Epidemiology | Distribution | Plasmodium falciparum | Medical research | Mortality | Africa | Antimalarials | Medicine, Experimental | Insecticides | Mosquitoes | Microscopy | Ligands | Parasites | Blood | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2/2013, Volume 56, Issue 3, pp. 383 - 397
Medical referrals | Malaria | Mortality | Plantations | Respiratory distress | Parasites | ARTICLES AND COMMENTARIES | Parasitemia | Vivax malaria | Falciparum malaria | Disease risks | Plasmodium knowlesi | malaria | Plasmodium vivax | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Parasitic diseases | Pharmacology. Drug treatments | Protozoal diseases | Biological and medical sciences | Antiparasitic agents | Human protozoal diseases | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Prospective Studies | Humans | Malaria, Vivax - epidemiology | Middle Aged | Malaria - mortality | Malaria, Vivax - mortality | Male | Malaysia | Parasitemia - drug therapy | Young Adult | Malaria, Falciparum - mortality | Time Factors | Malaria - epidemiology | Plasmodium falciparum - isolation & purification | Malaria, Falciparum - epidemiology | Adult | Female | Severity of Illness Index | Malaria, Falciparum - drug therapy | Risk Factors | Treatment Outcome | Antimalarials - therapeutic use | Parasitemia - mortality | Plasmodium knowlesi - isolation & purification | Artemisinins - therapeutic use | Malaria, Vivax - drug therapy | Plasmodium vivax - isolation & purification | Aged | Malaria - drug therapy | Causes of | Care and treatment | Research | Patient outcomes | Polymerase chain reaction | Comparative studies | Primates | Multivariate analysis | Index Medicus
Journal Article